Imaging procedures to diagnose prostate cancer;Bildgebende verfahren bei der diagnose des prostatakarzinoms

Urologe - Ausgabe A

Volumn 46, Issue 10, 2007, Pages 1435-1448

  Seitz, M ^a   Scher, B ^a   Scherr, M ^a   Tilki, D ^a,b   Schlenker, B ^a   Gratzke, C ^a   Schipf, A ^a   Stanislaus, P ^a   Muller Lisse U ^a   Reich, O ^a   Stief, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Imaging; Metabolic imaging; MRI MRS; PET CT; Prostate cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BIOCHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; ECHOGRAPHY; GERMANY; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA; REVIEW; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

BIOPSY; ENDOSONOGRAPHY; ENERGY METABOLISM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 35748961090     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1455-x     Document Type: Review

References (74)

1. Watanabe H, Igari D, Tanahasi Y et al. (1974) Development and application of new equipment for transrectal ultrasonography. J Clin Ultrasound 2: 91-98
2. McNeal JE (1981) The zonal anatomy of the prostate. Prostate 2: 35-49
3. Rifkin MD, Dahnert W, Kurtz AB (1990) State of the art: endorectal sonography of the prostate gland. Am J Roentgenol 154: 691-700
4. Sedelaar JP, Vijverberg PL, De Reijke TM et al. (2001) Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 40: 275-284
5. Cornud F, Belin X, Piron D et al. (1997) Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49: 709-715
6. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am J Roentgenol 174: 623-627
7. Song JM, Kim CB, Chung HC, Kane RL (2005) Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men. Yonsei Med J 46: 414-424
8. Kuligowska E, Barish MA, Fenlon HM, Blake M (2001) Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 220: 757-764
9. Rifkin MD, Alexander AA, Helinek TG, Merton DA (1991) Color Doppler as an adjunct to prostate ultrasound. Scand J Urol Nephrol Suppl 137: 85-89
10. Sauvain JL, Palascak P, Bourscheid D et al. (2003) Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 44: 21-30; discussion 30-31
11. Ismail M, Petersen RO, Alexander AA et al. (1997) Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 50: 906-912
12. Kelly IM, Lees WR, Rickards D (1993) Prostate cancer and the role of color Doppler US. Radiology 189: 153-156
13. Newman JS, Bree RL, Rubin JM (1995) Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195: 86-90
14. Cho JY, Kim SH, Lee SE (1998) Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography. J Ultrasound Med 17: 283-287
15. Cho JY, Kim SH, Lee SE (2000) Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur Urol 37: 443-448
16. Sakarya ME, Arslan H, Unal O et al. (1998) The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 82: 386-388
17. Remzi M, Dobrovits M, Reissigl A et al. (2004) Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 46: 451-456
18. Cho IR, Keener TS, Nghiem HV et al. (2000) Prostate blood flow characteristics in the chronic prostatitis/pelvic pain syndrome. J Urol 163: 1130-1133
19. Rifkin MD, Sudakoff GS, Alexander AA (1993) Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186: 509-513
20. Tong S, Cardinal HN, McLoughlin RF et al. (1998) Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24: 673-681
21. Garg S, Fortling B, Chadwick D et al. (1999) Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol 162: 1318-1321
22. Hamper UM, Trapanotto V, DeJong MR et al. (1999) Three-dimensional US of the prostate: early experience. Radiology 212: 719-723
23. Mehta SS, Azzouzi AR, Hamdy FC (2004) Three dimensional ultrasound and prostate cancer. World J Urol 22: 339-345
24. Sedelaar JP, Roermund JG van, Leenders GL van et al. (2001) Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 57: 914-920
25. Strasser H, Frauscher F, Klausser A et al. (2003) Three-dimensional transrectal ultrasound in staging of localised prostate cancer. J Urology 169: 299A
26. Bogers HA, Sedelaar JP, Beerlage HP et al. (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54: 97-104
27. Halpern EJ, Rosenberg M, Gomella LG (2001) Prostate cancer: contrast-enhanced us for detection. Radiology 219: 219-225
28. Frauscher F, Klauser A, Volgger H et al. (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167: 1648-1652
29. Halpern EJ, Ramey JR, Strup SE et al. (2005) Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104: 2373-2383
30. Amiel GE, Slawin KM (2006) Newer modalities of ultrasound imaging and treatment of the prostate. Urol Clin North Am 33: 329-337
31. Pepe P, Patane D, Panella P, Aragona F (2003) Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 6: 159-162
32. Hardeman SW, Causey JQ, Hickey DP, Soloway MS (1989) Transrectal ultrasound for staging prior to radical prostatectomy. Urology 34: 175-180
33. Rorvik J, Halvorsen OJ, Servoll E, Haukaas S (1994) Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br J Urol 73: 65-69
34. Bates TS, Gillatt DA, Cavanagh PM, Speakman M (1997) A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 79: 927-932
35. Colombo T, Schips L, Augustin H et al. (1999) Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol Nefrol 51: 1-4
36. Ozgur A, Onol FF, Turkeri LN (2004) Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy. Int Urol Nephrol 36: 369-373
37. Anagnostou T, Doumas K, Remzi M, Djavan B (2004) Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today? Prostate Cancer Prostatic Dis 7: 302-310
38. Drudi FM, Giovagnorio F, Carbone A et al. (2006) Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy - comparison with MRI. Ultraschall Med 27: 146-151
39. Tamsel S, Killi R, Apaydin E et al. (2006) The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy. Clin Radiol 61: 325-330; discussion 323-324
40. Schlemmer HP, Merkle J, Grobholz R et al. (2004) Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 14: 309-317
41. Seitz M, Scher B, Graser A et al. (2006) Advances in metabolic imaging in patients with elevated prostate specific antigen. EAU-EBU Update Series 4: 20-32
42. Mueller-Lisse UG, Vigneron DB, Hricak H et al. (2001) Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology 221: 380-390
43. Villers A, Puech P, Leroy X et al. (2007) Dynamic contrast-enhanced MRI for preoperative identification of localized prostate cancer. Eur Urol Suppl 6: 525-532
44. Engelbrecht MR, Jager GJ, Laheij RJ et al. (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12: 2294-2302
45. Heuck A, Scheidler J, Sommer B et al. (2003) MR imaging of prostate cancer. Radiologe 43: 464-473
46. Scheidler J, Hricak H, Vigneron DB et al. (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 213: 473-480
47. Graser A, Heuck A, Sommer B et al. (2007) Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. Am J Roentgenol 188: 84-90
48. Amsellem-Ouazana D, Younes P, Conquy S et al. (2005) Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 47: 582-586
49. Yuen JS, Thng CH, Tan PH et al. (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171: 1482-1486
50. Anastasiadis AG, Lichy MP, Nagele U et al. (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50: 738-748; discussion 748-749
51. Aus G, Abbou CC, Bolla M et al. (2005) EAU guidelines on prostate cancer. Eur Urol 48: 546-551
52. Sella T, Schwartz LH, Swindle PW et al. (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231: 379-385
53. Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference,.,Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 28: 1707-1723
54. Agus DB, Golde DW, Sgouros G et al. (1998) Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res 58: 3009-3014
55. Effert PJ, Bares R, Handt S et al. (1996) Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 155: 994-998
56. Oyama N, Akino H, Kanamaru H et al. (2002) 11C-acetate PET imaging of prostate cancer. J Nucl Med 43: 181-186
57. Seltzer MA, Barbaric Z, Belldegrun A et al. (1999) Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol 162: 1322-1328
58. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61: 3599-3603
59. Breeuwsma AJ, Pruim J, Jongen MM et al. (2005) In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 32: 668-673
60. Hara T, Kosaka N, Kishi H (1998) PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39: 990-995
61. Coleman R, DeGrado T, Wang S et al. (2000) Preliminary evaluation of F-18 Fluorocholine (FCH) as a PET tumor imaging agent. Clin Positron Imaging 3: 147
62. DeGrado TR, Coleman RE, Wang S et al. (2001) Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 61: 110-117
63. Hara T, Kosaka N, Kishi H (2002) Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 43: 187-199
64. Oyama N, Miller TR, Dehdashti F et al. (2003) 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44: 549-555
65. Kotzerke J, Volkmer BG, Glatting G et al. (2003) Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 42: 25-30
66. Larson SM, Morris M, Gunther I et al. (2004) Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med 45: 366-373
67. Toth G, Lengyel Z, Balkay L et al. (2005) Detection of prostate cancer with 11C-methionine positron emission tomography. J Urol 173: 66-69; discussion 69
68. Yoshida S, Nakagomi K, Goto S et al. (2005) 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urol Int 74: 214-220
69. Jong IJ de, Pruim J, Elsinga PH et al. (2002) Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 42: 18-23
70. Yamaguchi T, Lee J, Uemura H et al. (2005) Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32: 742-748
71. Scher B, Seitz M, Albinger W et al. (2007) Value of (11)C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 34: 45-53
72. Reske SN, Blumstein NM, Neumaier B et al. (2006) Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 47: 1249-1254
73. Jong IJ de, Pruim J, Elsinga PH et al. (2003) Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44: 331-335
74. Kotzerke J, Prang J, Neumaier B et al. (2000) Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 27: 1415-1419